Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Identification of differential expressed lncRNAs in human thyroid cancer by a genome‐wide analyses
- W. Lu, Yongcan Xu, Jiewei Xu, Zhong Wang, Guochao Ye
- Biology, MedicineCancer medicine
- 20 June 2018
TLDR
Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma
- Hao Jiang, Xuefei Shi, Wei-Yu Lu
- Biology, MedicineOncoTargets and therapy
- 11 September 2019
TLDR
EZH2 promotes gastric cancer cells proliferation by repressing p21 expression.
- Jiewei Xu, Zhong Wang, Guochao Ye
- BiologyPathology, research and practice
- 1 June 2019
The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.
- Yongcan Xu, M. Qiu, Ming Sun
- BiologyMolecular therapy : the journal of the American…
- 25 March 2021
Application of Minimally Invasive Video-assisted Technique in Papillary Thyroid Microcarcinoma
- Weili Gao, Liwei Liu, Guochao Ye, Li-ping Song
- MedicineSurgical laparoscopy, endoscopy & percutaneous…
- 1 October 2013
TLDR
Bilateral Areolar Approach Endoscopic Thyroidectomy for Low-risk Papillary Thyroid Carcinoma: A Review of 137 Cases in a Single Institute
- Weili Gao, Liwei Liu, Guochao Ye, Wei Lu, L. Teng
- MedicineSurgical laparoscopy, endoscopy & percutaneous…
- 1 February 2015
TLDR
Down-regulated expression of Rap 1 GAP predicts unfavorable prognosis in diffuse type gastric cancer and may be correlated with EMT
- Weili Gao, Guochao Ye, Liwei Liu, D. Gu
- Medicine
- 2017
TLDR
Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway.
- Yongcan Xu, Jun Lu, Guochao Ye
- Biology, MedicinePathology, research and practice
- 1 March 2022
LncRNA RP11-138J23.1 Contributes to Gastric Cancer Progression by Interacting With RNA-Binding Protein HuR
- Yongcan Xu, Xiang Yu, Feng-qi Nie
- BiologyFrontiers in Oncology
- 22 March 2022
TLDR